within Pharmacolibrary.Drugs.ATC.J;

model J01CR01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0002216666666666667,
    adminDuration  = 600,
    adminMass      = 1500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0134,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0128,
    k12             = 16.7,
    k21             = 16.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01CR01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Combination of ampicillin, a broad-spectrum penicillin antibiotic, and a beta-lactamase inhibitor (commonly sulbactam); used for the treatment of infections caused by susceptible bacteria, particularly where beta-lactamase producing strains are present. Approved and widely used clinically, especially in hospital settings for severe infections.</p><h4>Pharmacokinetics</h4><p>Adults, both sexes, general population with normal renal function receiving ampicillin/sulbactam intravenously.</p><h4>References</h4><ol><li><p>Dulhunty, JM, et al., &amp; Lipman, J (2024). Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial. <i>JAMA</i> 332(8) 629–637. DOI:<a href=&quot;https://doi.org/10.1001/jama.2024.9779&quot;>10.1001/jama.2024.9779</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38864155/&quot;>https://pubmed.ncbi.nlm.nih.gov/38864155</a></p></li><li><p>Setiawan, E, et al., &amp; Roberts, JA (2023). Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult Patients. <i>Clinical pharmacokinetics</i> 62(4) 573–586. DOI:<a href=&quot;https://doi.org/10.1007/s40262-023-01219-5&quot;>10.1007/s40262-023-01219-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36853585/&quot;>https://pubmed.ncbi.nlm.nih.gov/36853585</a></p></li><li><p>Ripa, S, et al., &amp; Prenna, M (1990). Pharmacokinetics of sulbactam/ampicillin in humans after intravenous and intramuscular injection. <i>Chemotherapy</i> 36(3) 185–192. DOI:<a href=&quot;https://doi.org/10.1159/000238765&quot;>10.1159/000238765</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2338029/&quot;>https://pubmed.ncbi.nlm.nih.gov/2338029</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01CR01;
